- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07578194
Coercive Control and Intimate Partner Violence (CCVCS)
Coercive Control and Intimate Partner Violence: Examining the Relationships Between Exposure to Violence and Victims' Physical and Mental Health Outcomes
Coercive control (CC) is increasingly recognized as a central component of intimate partner violence (IPV) and a major determinant of victims' health outcomes. While widely integrated into policy and legal frameworks in several countries, CC remains insufficiently explored in the French research context, particularly regarding its clinical and psychopathological dimensions. This gap may limit the identification of victims and the provision of appropriate care.
The present study aims to investigate the association between exposure to coercive control and physical and mental health outcomes among victims of intimate partner violence. By improving the understanding of CC-related health impacts, this research seeks to support better identification of high-risk situations and inform clinical and public health interventions.
Study Overview
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Fatima F LE GRIGUER, Principal Investigator
- Phone Number: 00 33 1 49 36 72 38
- Email: fatima.le-griguer@ght-gpne.fr
Study Locations
-
-
Île-de-France Region
-
Aulnay-sous-Bois, Île-de-France Region, France, 93600
- CHI Robert Ballanger
-
Contact:
- Nour BEKOUCHE, Head manager
- Phone Number: 0033141708631
- Email: nour.bekouche@ght-gpne.fr
-
Principal Investigator:
- Fatima Le Griguer, psychologist
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Women aged 18 years and older, who have experienced an intimate partner relationship involving violence for at least three months (currently in the relationship or separated).
- Women identified as victims of intimate partner violence.
- Sufficient proficiency in French to complete self-administered questionnaires and participate in interviews.
- No objection to participation in the study (non-opposition).
- Affiliation with a French social security scheme or eligibility for universal health coverage (Couverture Maladie Universelle, CMU).
Exclusion Criteria:
- Individuals under legal protection in accordance with the French Public Health Code (Articles L.1121-5 to L.1121-8 and L.1122-1-2), with the exception of pregnant or breastfeeding women.
- Cognitive impairment or severe intellectual disability preventing comprehension of the questionnaires.
- Severe and unstable psychiatric disorders (e.g., schizophrenia, delusional disorders, acute bipolar disorder).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Questionnaire arm
Participants will complete online questionnaires via the Qualtrics platform
|
Participants will complete online questionnaires via the Qualtrics platform at baseline and at 6 months post-enrollment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Coercive Control Screening Scale
Time Frame: Measure of CCSS between inlusion and month 6
|
Measure of Coercive Control Screening Scale (CCSS).
Minimal scale = 0, maximal scale = 44.
Higher score means worse outcome
|
Measure of CCSS between inlusion and month 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measure of Hospital Anxiety and Depression scale (HAD scale)
Time Frame: Measure of HHAD scale between inclusion and month 6
|
correlation between HAD scale and CCSS scale.
Minimal scale = 0, maximal scale = 42.
Higher score means worse outcome
|
Measure of HHAD scale between inclusion and month 6
|
|
Severity of post-traumatic stress disorder symptoms
Time Frame: at inclusion and month 6
|
Severity of post-traumatic stress disorder (PTSD) symptoms assessed by the PTSD Checklist for DSM-5 (PCL-5), based on total score and DSM-5 clinical thresholds.
Minimal scale = 0, maximal scale = 80.
Higher score means worse outcome
|
at inclusion and month 6
|
|
International Trauma Questionnaire (ITQ).
Time Frame: Inclusion and month 6
|
International Trauma Questionnaire (ITQ), according to ICD-11 criteria.
Minimal scale = 0, maximal scale = 72.
Higher score means worse outcome
|
Inclusion and month 6
|
|
Severity of emotional dysregulation
Time Frame: inclusion and month 6
|
Severity of emotional dysregulation assessed using the Difficulties in Emotion Regulation Scale - French version (DERS-F).
Minimal scale = 36, maximal scale = 180.
Higher score means worse outcome
|
inclusion and month 6
|
|
Short Form Health Survey (SF-12)
Time Frame: inclusion and month 6
|
Health-related quality of life assessed using the 12-Item Short Form Health Survey (SF-12), including physical and mental component summary scores.
optimal scale more than 40.
scale < 40 means worse outcome
|
inclusion and month 6
|
|
Brief Pain Inventory
Time Frame: at inclusion and month 6
|
Pain intensity and functional impact assessed using the Brief Pain Inventory (BPI).
mninimal scale = 0, maximal scale = 10.
Higher score means worse outcome
|
at inclusion and month 6
|
|
Coercive Control Scale (CCSS)
Time Frame: inclusion and month 6
|
Analysis of score distribution on the Coercive Control Scale (CCSS) to determine a clinically relevant threshold for coercive control.
Minimal scale = 0, maximal scale = 44.
Higher score means worse outcome
|
inclusion and month 6
|
|
Woman Abuse Screening Tool (WAST)
Time Frame: inclusion and month 6
|
Intimate partner violence assessed using the Woman Abuse Screening Tool (WAST).
minimal scale = 0, maximal scale = 16.
Higher score means worse outcome
|
inclusion and month 6
|
Collaborators and Investigators
Investigators
- Principal Investigator: fatima F Le Griguer, psychologist, CHI Robert Balanger of GHT GPNE
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GHT GPNE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coercive Control
-
Charite University, Berlin, GermanyFederal Ministry of Health, GermanyCompleted
-
Laval UniversityUnknownImpulse Control DisorderCanada
-
M.D. Anderson Cancer CenterRecruitingImpulse Control DisorderUnited States
-
SandozCompletedImpulse Control DisorderKorea, Republic of
-
University of MiamiNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Completed
-
Centre Hospitalier Universitaire, AmiensUnknownParkinson | Impulse Control DisorderFrance
-
The University of Hong KongNot yet recruitingIntervention | ControlHong Kong
-
Assistance Publique - Hôpitaux de ParisRecruitingControl ConditionFrance
-
Vanderbilt UniversityNational Institute of Mental Health (NIMH)RecruitingPrevention | ControlUnited States
-
Massachusetts General HospitalCompletedHealthy ControlUnited States
Clinical Trials on questionnaire
-
H. Lee Moffitt Cancer Center and Research InstituteSan Diego State University; University of Minnesota; University of ArizonaCompletedAnxiety | Psychological StressUnited States
-
Centre Hospitalier Universitaire de NiceCompletedGeneral Population | TDAH | Children Aged 5 to 18 YearsFrance
-
Stanford UniversityRecruitingAstigmatism | Nearsightedness | FarsightednessUnited States
-
University Medical Center GoettingenCompletedOrofacial Pain | Sleep ProblemsGermany
-
University of LiegeCompletedCritical Illness | Covid19 | Psychological Stress | FamilyBelgium
-
Imperial College Healthcare NHS TrustNot yet recruitingCervical Myelopathy
-
Children's Hospitals and Clinics of MinnesotaCompletedFirearm Injury | Firearm Safety | Firearm OwnershipUnited States
-
Imperial College LondonRoyal Marsden NHS Foundation Trust; University College London Hospitals; The... and other collaboratorsCompleted
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
University Hospital, Clermont-FerrandCompletedQuality of Life | Dentin HypersensitivityFrance